Fennec Pharmaceuticals Inc. Forecast, price target & analysts
Fennec Pharmaceuticals Inc. Target price 2026 - Analyst rating & recommendation
Fennec Pharmaceuticals Inc. Classifications & Recommendation
Fennec Pharmaceuticals Inc. Price Target
| Target Price | $18.36 |
| Price | $10.95 |
| Potential |
67.67%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Fennec Pharmaceuticals Inc. 2027 .
The average Fennec Pharmaceuticals Inc. target price is $18.36.
This is
67.67%
register free of charge
$21.00
91.78%
register free of charge
$16.16
47.58%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Fennec Pharmaceuticals Inc. to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Fennec Pharmaceuticals Inc. stock has an average upside potential 2027 of
67.67%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 44.64 | 73.65 |
| 6.10% | 64.99% | |
| Net Margin | -21.82% | 14.44% |
| 2,257.44% | 166.18% |
8 Analysts have issued a sales forecast Fennec Pharmaceuticals Inc. 2026 . The average Fennec Pharmaceuticals Inc. sales estimate is
This results in the following potential growth metrics:
8 Fennec Pharmaceuticals Inc. Analysts have issued a net profit forecast 2026. The average Fennec Pharmaceuticals Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.34 | 0.30 |
| 1,600.00% | 188.24% | |
| P/E | 36.07 | |
| EV/Sales | 4.65 |
8 Analysts have issued a Fennec Pharmaceuticals Inc. forecast for earnings per share. The average Fennec Pharmaceuticals Inc. EPS is
This results in the following potential growth metrics and future valuations:
Fennec Pharmaceuticals Inc....
Current Fennec Pharmaceuticals Inc. Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 09 2026 |
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Aug 12 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 22 2026 |
| Wedbush |
Locked
➜
Locked
|
Locked | Apr 16 2026 |
| Piper Sandler |
Locked
➜
Locked
|
Locked | Jan 09 2026 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Aug 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 09 2026 |
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Aug 12 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 22 2026 |
|
Locked
Wedbush:
Locked
➜
Locked
|
Apr 16 2026 |
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Jan 09 2026 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Aug 21 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
